How many 8-K filings has Black Diamond Therapeutics, Inc. filed?

Black Diamond Therapeutics, Inc. (BDTX) has 10 8-K (Current Event Report) filings on record, spanning Jan 2024 to Dec 2025.

What is a 8-K filing?

A 8-K is an SEC filing known as "Current Event Report." Filed to announce significant events or material changes such as acquisitions, executive departures, earnings announcements, or bankruptcy filings.

Where can I read Black Diamond Therapeutics, Inc. 8-K filings in plain English?

ReadTheFiling provides AI-powered plain-English summaries of all Black Diamond Therapeutics, Inc. 8-K filings, including risk assessment, sentiment analysis, and key financial figures.

Black Diamond Therapeutics, Inc. (BDTX) — 8-K Filings

All 8-K filings from Black Diamond Therapeutics, Inc.. Browse 10 Current Event Report reports with AI-powered summaries and risk analysis.

8-K Filings (10)

8-K Filing — Dec 3, 2025
Black Diamond Therapeutics Files 8-K on Shareholder Vote Matters — Jun 12, 2025 Risk: low
Black Diamond Therapeutics, Inc. filed an 8-K on June 12, 2025, to report on matters submitted to a vote of its security holders. The filing does not contain de
Black Diamond Therapeutics Enters Material Definitive Agreement — Mar 19, 2025 Risk: medium
Black Diamond Therapeutics, Inc. announced on March 18, 2025, that it entered into a material definitive agreement. The company, formerly known as Aset Therapeu
Black Diamond Therapeutics Appoints New CMO, Adds Directors — Oct 7, 2024 Risk: medium
Black Diamond Therapeutics, Inc. announced on October 7, 2024, the appointment of Dr. David Pesman as Chief Medical Officer and the election of Dr. David Pesman
Black Diamond Therapeutics Files 8-K — Sep 23, 2024 Risk: low
Black Diamond Therapeutics, Inc. filed an 8-K on September 23, 2024, to report on several key events. The filing includes information regarding Regulation FD di
Black Diamond Therapeutics Files 8-K — Jun 6, 2024 Risk: low
Black Diamond Therapeutics, Inc. filed an 8-K on June 6, 2024, reporting amendments to its articles of incorporation or bylaws, submission of matters to a vote
Black Diamond Therapeutics Appoints New Director, Adjusts Compensation — Apr 11, 2024 Risk: medium
Black Diamond Therapeutics, Inc. announced on April 10, 2024, a change in its board of directors. Dr. David Epstein has been appointed as a new Class II directo
Black Diamond Therapeutics Files 8-K — Mar 12, 2024 Risk: low
On March 12, 2024, Black Diamond Therapeutics, Inc. filed an 8-K report. The filing primarily concerns the company's financial condition and results of operatio
Black Diamond Therapeutics Reports Officer/Director Changes — Jan 18, 2024
Black Diamond Therapeutics, Inc. filed an 8-K on January 18, 2024, reporting an event that occurred on January 17, 2024. The filing indicates a change in direct
Black Diamond Therapeutics Files 8-K for Regulation FD Disclosure — Jan 4, 2024
Black Diamond Therapeutics, Inc. filed an 8-K on January 4, 2024, to disclose information under Regulation FD and to include financial statements and exhibits.

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX